Log in | Register

Oral care with chlorhexidine: beware!

Lila Bouadma| Michael Klompas
Editorial
Volume 44, Issue 7 / July , 2018

Pages 1153 - 1155

No abstract available.

References

  1. Klompas M, Branson R, Eichenwald EC, Greene LR, Howell MD, Lee G, Magill SS, Maragakis LL, Priebe GP, Speck K, Yokoe DS, Berenholtz SM (2014) Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 35:915–936
    • View reference on publisher's website
    • View reference on PubMed
  2. Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, Kollef M, Li Bassi G, Luna CM, Martin-Loeches I, Paiva JA, Read RC, Rigau D, Timsit JF, Welte T, Wunderink R (2017) International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociacion Latinoamericana del Torax (ALAT). Eur Respir J. https://doi.org/10.1183/13993003.00582-2017
  3. Klompas M, Speck K, Howell MD, Greene LR, Berenholtz SM (2014) Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis. JAMA Intern Med 174:751–761
    • View reference on publisher's website
    • View reference on PubMed
  4. Plantinga NL, Wittekamp BH, Leleu K, Depuydt P, Van den Abeele AM, Brun-Buisson C, Bonten MJ (2016) Oral mucosal adverse events with chlorhexidine 2% mouthwash in ICU. Intensive Care Med 42:620–621
  5. Price R, MacLennan G, Glen J (2014) Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. BMJ 348:g2197
    • View reference on publisher's website
    • View reference on PubMed
  6. Klompas M, Li L, Kleinman K, Szumita PM, Massaro AF (2016) Associations between ventilator bundle components and outcomes. JAMA Intern Med 176:1277–1283
    • View reference on publisher's website
    • View reference on PubMed
  7. Azevedo JR, Montenegro WS, Sousa CA, Silva MM, Leitao AL, Maranhao JP, Araujo RS (2017) Ventilator-associated events: prevalence, outcome, and preventability. Intensive Care Med Exp 5(Suppl 2):44
  8. Klompas M (2017) Oropharyngeal decontamination with antiseptics to prevent ventilator-associated pneumonia: rethinking the benefits of chlorhexidine. Semin Respir Crit Care Med 38:381–390
    • View reference on publisher's website
    • View reference on PubMed
  9. Odedra KM, Farooque S (2014) Chlorhexidine: an unrecognised cause of anaphylaxis. Postgrad Med J 90:709–714
    • View reference on publisher's website
    • View reference on PubMed
  10. Garvey LH, Kroigaard M, Poulsen LK, Skov PS, Mosbech H, Venemalm L, Degerbeck F, Husum B (2007) IgE-mediated allergy to chlorhexidine. J Allergy Clin Immunol 120:409–415
    • View reference on publisher's website
    • View reference on PubMed
  11. Opstrup MS, Malling HJ, Kroigaard M, Mosbech H, Skov PS, Poulsen LK, Garvey LH (2014) Standardized testing with chlorhexidine in perioperative allergy—a large single-centre evaluation. Allergy 69:1390–1396
    • View reference on publisher's website
    • View reference on PubMed
  12. Kampf G (2016) Acquired resistance to chlorhexidine—is it time to establish an ‘antiseptic stewardship’ initiative? J Hosp Infect 94:213–227
    • View reference on publisher's website
    • View reference on PubMed
  13. La Combe B, Bleibtreu A, Messika J, Fernandes R, Clermont O, Branger C, Billard-Pomares T, Barnaud G, Magdoud F, Eveillard M, Kouatchet A, Lasocki S, Asfar P, Corvec S, Lakhal K, Armand-Lefevre L, Wolff M, Timsit JF, Bourdon S, Reignier J, Martin S, Fihman V, de Prost N, Bador J, Charles PE, Goret J, Boyer A, Wallet F, Jaillette E, Nseir S, Landraud L, Ruimy R, Danin PE, Dellamonica J, Cremniter J, Frat JP, Jaureguy F, Clec’h C, Decre D, Maury E, Dreyfuss D, Denamur E, Ricard JD (2018) Decreased susceptibility to chlorhexidine affects a quarter of Escherichia coli isolates responsible for pneumonia in ICU patients. Intensive Care Med 44(4):531–533
  14. Deschepper M, Waegeman W, Eeckloo K, Vogelaers D, Blot S (2018) Effects of chlorhexidine gluconate oral care on hospital mortality. Intensive Care Med. https://doi.org/10.1007/s00134-018-5171-3
    • View reference on PubMed
  15. De Marco MF, Lorenzoni L, Addari P, Nante N (2002) Evaluation of the capacity of the APR-DRG classification system to predict hospital mortality. Epidemiol Prev 26:183–190
    • View reference on PubMed
  16. Hua F, Xie H, Worthington HV, Furness S, Zhang Q, Li C (2016) Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database Syst Rev 10:CD008367
    • View reference on PubMed
  17. Bouadma L, Karpanen T, Elliott T (2018) Chlorhexidine use in adult patients on ICU. Intensive Care Med. https://doi.org/10.1007/s00134-018-5137-5

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement